CClinicalTrials.gg
WithdrawnNCT04104295Updated Apr 20, 2021

The Use of Ultrasound in Nasogastric Tube Placement in Children Admitted to the Pediatric ICU

An interventional study of Ultrasound following X-ray in Nasogastric Tube, sponsored by Yale University. Withdrawn. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2021-04-20.

Sponsored by Yale University · Not applicable, Interventional, and Diagnostic

Why this study was withdrawn
Study never began.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
0 Years to 18 Years
Sex
All
01

Study summary

The purpose of this study is to determine if ultrasound (US), when used by the clinician, can determine the presence of nasogastric tube (NGT) in the stomach of patients admitted to the pediatric intensive care unit (PICU).

Read the detailed description

Currently, the standard of care is to routinely obtain an X-ray (XR) after every nasogastric tube (NGT) placement in the pediatric intensive care unit (PICU). After obtaining informed consent and the child's assent, a short (less than 10 minutes) ultrasound (US) scan of the abdomen within 2 hours of the routine XR.

02

Conditions studied

  • Nasogastric Tube

Keywords

  • nasogastric tube
  • ultrasound
03

In context

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • PICU patient undergoing routine NGT insertion by nursing staff

Exclusion criteria

Exclusion Criteria:

  • Any contraindication for US probe placement such as skin infection and abdominal wounds.
  • Hemodynamically unstable patients.
  • Patients for whom NGT placement will not be verified by XR, such as Ataxia Telangiectasia patients.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Ultrasound following X-ray

    An ultrasound scan of the abdomen within 2 hours of the routine X-ray will be performed by a physician blinded to the X-ray results.

    Diagnostic Test: Ultrasound following X-ray

Interventions

  • Diagnostic testUltrasound following X-ray

    A short (less than 10 minutes) ultrasound (US) scan of the abdomen within 2 hours of the routine X-ray (XR). The performer will be a physician who received a focused training on relevant US views, blinded to the XR image and report.

    Also known as: Ultrasound

06

What researchers measure

Primary outcomes

  1. Correct placement of NG tube

    The operational definition will be the number of correct identification of NG tube position using ultrasound, as compared to the official X-ray read.

    Time frame: Up to 10 minutes

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04104295
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Sep 26, 2019
Start date
Mar 24, 2020 (estimated)
Primary completion
Sep 30, 2020 (estimated)
Completion
Jan 31, 2021 (estimated)
Last update
Apr 20, 2021

Study contacts

Eitan Neeman, MD
principal investigator · Yale University - MEDPED Critical Care

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion